Lars Maegdefessel Selected Research

bivalirudin (Angiomax)

6/2009	Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.
10/2008	Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Maegdefessel Research Topics

Disease

36	Atherosclerosis 04/2024 - 01/2009
29	Inflammation (Inflammations) 03/2023 - 01/2009
23	Abdominal Aortic Aneurysm 09/2023 - 01/2011
22	Aneurysm (Aneurysms) 09/2023 - 09/2011
15	Atherosclerotic Plaque (Atheroma) 01/2023 - 03/2014
15	Thrombosis (Thrombus) 01/2023 - 11/2006
12	Vascular Diseases (Vascular Disease) 01/2023 - 01/2013
10	Rupture 01/2023 - 09/2011
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 05/2015
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 03/2014
7	Hyperplasia 01/2022 - 05/2012
7	Stroke (Strokes) 12/2021 - 09/2008
6	Carotid Artery Diseases 02/2024 - 10/2016
5	Disease Progression 01/2023 - 02/2012
4	Aortic Aneurysm (Aneurysm, Aortic) 01/2023 - 06/2016
4	Carotid Stenosis (Carotid Artery Stenosis) 01/2022 - 02/2017
4	Fibrosis (Cirrhosis) 06/2021 - 01/2014
4	Coronary Disease (Coronary Heart Disease) 05/2014 - 01/2009
3	Peripheral Arterial Disease 09/2022 - 02/2014
3	Heart Failure 01/2020 - 04/2016
3	Hypoxia (Hypoxemia) 01/2019 - 10/2016
3	Myocardial Infarction 04/2016 - 09/2008
3	Hemorrhage 11/2011 - 09/2008
3	Thromboembolism 11/2011 - 03/2010
3	Atrial Fibrillation 05/2010 - 09/2008
2	Popliteal Artery Aneurysm 01/2023 - 01/2016
2	Neoplasms (Cancer) 08/2022 - 02/2019
2	Aortic Dissection 01/2021 - 01/2018
2	Aortic Rupture 01/2018 - 02/2012
2	Type 2 Diabetes Mellitus (MODY) 08/2015 - 02/2010
2	Diabetes Mellitus 08/2015 - 02/2010
2	Thrombocytopenia (Thrombopenia) 06/2009 - 06/2009
1	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2023

Drug/Important Bio-Agent (IBA)

20	MicroRNAs (MicroRNA)IBA 01/2023 - 05/2013
13	RNA (Ribonucleic Acid)IBA 02/2024 - 05/2015
13	Apolipoproteins E (ApoE)IBA 01/2023 - 09/2011
11	Long Noncoding RNAIBA 01/2023 - 01/2018
8	Biomarkers (Surrogate Marker)IBA 03/2023 - 09/2011
8	LipidsIBA 11/2022 - 03/2014
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2014
8	Pancreatic Elastase (Elastase)IBA 01/2021 - 01/2011
8	Angiotensin IIIBA 01/2021 - 09/2011
7	CholesterolIBA 01/2023 - 07/2015
7	Heparin (Liquaemin)FDA LinkGeneric 11/2011 - 11/2006
7	AnticoagulantsIBA 09/2010 - 11/2006
6	Messenger RNA (mRNA)IBA 01/2023 - 10/2016
6	Transcription Factors (Transcription Factor)IBA 10/2022 - 05/2015
6	Enoxaparin (Lovenox)FDA LinkGeneric 11/2011 - 06/2008
5	mouse MIRN29 microRNAIBA 06/2021 - 01/2012
5	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2011 - 11/2006
4	ApolipoproteinsIBA 01/2023 - 10/2018
4	Antisense OligonucleotidesIBA 01/2023 - 01/2012
4	CollagenIBA 01/2023 - 12/2018
4	Untranslated RNA (Noncoding RNA)IBA 01/2023 - 06/2016
4	ChemokinesIBA 09/2022 - 01/2009
3	Proteoglycans (Proteoglycan)IBA 01/2023 - 01/2021
3	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 01/2014
3	ElastinIBA 01/2023 - 02/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 04/2009
3	LDL Receptors (LDL Receptor)IBA 01/2021 - 10/2018
3	Histones (Histone)IBA 01/2021 - 01/2019
3	CytokinesIBA 10/2017 - 10/2016
3	AntithrombinsIBA 09/2010 - 03/2010
3	Dabigatran FDA Link 09/2010 - 03/2010
3	argatroban (MPQA)FDA Link 04/2010 - 06/2009
3	Fondaparinux (Arixtra)FDA Link 10/2008 - 11/2006
2	EpitopesIBA 02/2024 - 07/2023
2	Circular RNAIBA 09/2023 - 10/2019
2	Small Cytoplasmic RNAIBA 07/2023 - 01/2023
2	LigandsIBA 03/2023 - 03/2014
2	Nicotine FDA Link 01/2023 - 02/2012
2	ElementsIBA 01/2023 - 05/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 02/2014
2	Complement System Proteins (Complement)IBA 10/2022 - 01/2020
2	Activating Transcription Factor 3IBA 10/2022 - 09/2022
2	LipopolysaccharidesIBA 09/2022 - 01/2021
2	InterferonsIBA 01/2022 - 10/2016
2	Cyclin-Dependent Kinase Inhibitor p15IBA 01/2019 - 03/2014
2	Small Interfering RNA (siRNA)IBA 01/2019 - 05/2015
2	RivaroxabanIBA 11/2011 - 03/2010
2	Warfarin (Coumadin)FDA LinkGeneric 05/2010 - 03/2010
2	FibrinIBA 04/2010 - 04/2010
2	Eptifibatide (Integrilin)FDA Link 04/2010 - 06/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2010 - 09/2008
2	Clopidogrel (Plavix)FDA Link 03/2010 - 09/2008
2	Insulin (Novolin)FDA Link 02/2010 - 01/2009
2	bivalirudin (Angiomax)FDA Link 06/2009 - 10/2008
1	niraparibIBA 04/2024
1	InflammasomesIBA 01/2024
1	Waste Products (Waste Product)IBA 06/2023
1	CXCR4 Receptors (CXCR4 Receptor)IBA 03/2023
1	CXC ChemokinesIBA 03/2023
1	myocardinIBA 01/2023

Therapy/Procedure

22	Therapeutics 01/2023 - 05/2010
6	Catheters 01/2020 - 06/2008
4	Cardiac Catheters 04/2010 - 06/2008
3	Ligation 09/2022 - 11/2017
2	Carotid Endarterectomy 01/2022 - 01/2019
2	Stents 09/2015 - 05/2012
2	Percutaneous Coronary Intervention 09/2008 - 06/2008